News

The complete study findings have been submitted for presentation at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD), in Stockholm, Sweden, in

At its initiation, the Phase 2 single blind study in chronic kidney disease patients called for the comparison of two different Heplisav regimens, a single-dose vaccine and a

Acrux is an Australian drug delivery company, developing and commercialising a range of patient-preferred, patented pharmaceutical products for global markets, using its innovative technology to administer drugs through

BioGenes said that the results confirmed the observation of several contract manufacturers that generic HCP assays are only of limited use for detection of HCPs during manufacturing processes.

TD-1211 is a potent, multivalent inhibitor of the mu opioid receptor designed to alleviate gastrointestinal side effects of opioid analgesic therapy without affecting analgesia. TD-1211 has been administered

King Pharmaceuticals Canada claimed that the new EpiPen is now the only epinephrine auto-injector with built-in needle protection before, during, and after use. The new EpiPen also features

China Shenghuo has posted a net income attributable to stockholders for the fourth quarter 2009 of $0.2m, compared with a net loss of $2.4m for the fourth quarter

Reportedly, MDV3100 demonstrated anti-tumor activity in patients with late-stage prostate cancer as evaluated by reductions in prostate specific antigen (PSA) levels, radiographic findings and circulating tumor cell (CTC)

Reportedly, four new business units will be created namely Primary Care, Multiple Sclerosis, Psychiatry/Neuroscience and respiratory/Transplant/Infectious Disease. The changes will be implemented from May 1 and impact approximately